Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lynn

Showing results (171-180 of 240) with videos related to

Pageof 24
Sort By:
Breast Cancer Research and Treatment|December 13, 2016
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancerJason D Robarge, Zereunesay Desta, Anne T Nguyen, et al.
Breast Cancer Research and Treatment|August 31, 2018
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)Sherry Shen, Joseph M Unger, Katherine D Crew, et al.
Cancer|October 22, 2025
Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trialsGillian Gresham, N Lynn Henry, Hanna Bandos, et al.
Journal of Cancer Survivorship : Research and Practice|March 23, 2024
Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providersKimberley T Lee, Brian D Gonzalez, Carley Geiss, et al.
Menopause (New York, N.Y.)|May 21, 2009
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapyJulie L Otte, David Flockhart, Daniel Hayes, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|February 16, 2026
Time-course based assessment of patient factors and their relationship to chemotherapy induced peripheral neuropathyCarla Bou Dargham, Ken B Johnson, Alper Sen, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 20, 2023
Correction to: Impact of the Integrative Oncology Scholars Program on Oncology Providers' Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology CareZachary O Kadro, Sara Snyder, Rita Benn, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 1, 2023
Impact of the Integrative Oncology Scholars Program on Oncology Providers' Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology CareZachary O Kadro, Sara Snyder, Rita Benn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 2022
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptomsDaniel L Hertz, Julie A Douglas, Robert M Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral NeuropathyDaniel L Hertz, Kelley M Kidwell, Kiran Vangipuram, et al.
Pageof 24

Showing results (171-180 of 240) with videos related to

Sort By:
Pageof 24
Breast Cancer Research and Treatment|December 13, 2016
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancerJason D Robarge, Zereunesay Desta, Anne T Nguyen, et al.
Breast Cancer Research and Treatment|August 31, 2018
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)Sherry Shen, Joseph M Unger, Katherine D Crew, et al.
Cancer|October 22, 2025
Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trialsGillian Gresham, N Lynn Henry, Hanna Bandos, et al.
Journal of Cancer Survivorship : Research and Practice|March 23, 2024
Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providersKimberley T Lee, Brian D Gonzalez, Carley Geiss, et al.
Menopause (New York, N.Y.)|May 21, 2009
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapyJulie L Otte, David Flockhart, Daniel Hayes, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|February 16, 2026
Time-course based assessment of patient factors and their relationship to chemotherapy induced peripheral neuropathyCarla Bou Dargham, Ken B Johnson, Alper Sen, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 20, 2023
Correction to: Impact of the Integrative Oncology Scholars Program on Oncology Providers' Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology CareZachary O Kadro, Sara Snyder, Rita Benn, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 1, 2023
Impact of the Integrative Oncology Scholars Program on Oncology Providers' Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology CareZachary O Kadro, Sara Snyder, Rita Benn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 2022
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptomsDaniel L Hertz, Julie A Douglas, Robert M Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral NeuropathyDaniel L Hertz, Kelley M Kidwell, Kiran Vangipuram, et al.
Pageof 24